ATRA
Atara Biotherapeutics Inc
9.50$
+12.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -5,088.9% | -1,084.2% | -425.4% | -2,251.0% | -53.3% | -42.2% | |
| – | – | – | – | – | – | – | – | 234.6% | 45.9% | 8.9% | 56.3% | 3.9% | 2.0% | |
| – | – | – | – | – | – | – | – | 1,445.7% | 264.8% | 84.7% | 529.4% | 20.9% | 8.1% | |
| – | – | – | – | – | – | – | – | 1,449.4% | 283.2% | 5.7% | – | – | – | |
| – | – | – | – | – | – | – | – | 1,792.9% | 258.5% | -96.7% | 178.9% | -24.0% | -86.7% | |
| – | – | – | – | – | – | – | – | 127.1% | 52.0% | 6.6% | 14.3% | 0.2% | 0.0% | |
| – | – | – | – | – | – | – | – | -3,398.9% | 109.4% | 319.2% | 1,444.8% | 6.7% | 15.0% | |
| – | – | – | – | – | – | – | – | 42.8% | 6.1% | 1.0% | – | – | – | |
| – | – | – | – | – | – | – | – | -42.8% | -6.1% | -1.0% | -1.1% | – | – | |
| – | – | – | – | – | – | – | – | -11.0% | -1.2% | 47.3% | -11.0% | -0.7% | -0.2% | |
| – | – | – | – | – | – | – | – | 12,037.6% | 511.0% | 83.5% | 23.4% | 46.0% | 13.3% | |
| – | – | – | – | – | – | – | – | 3,549.7% | -463.7% | -22.6% | -782.7% | -0.6% | -13.8% | |
| – | – | – | – | – | – | – | – | -5,216.0% | -1,136.2% | -432.0% | -2,265.3% | -53.5% | -42.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.